GSK Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

LSE:GSK Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
30 Oct 24BuyUK£99,646Jonathan SymondsIndividual7,150UK£13.94
20 Jun 24BuyUK£32,291Jonathan SymondsIndividual2,000UK£16.15
20 Jun 24BuyUK£7,196Wendy Mira BeckerIndividual446UK£16.14
01 Feb 24BuyUK£54,972Jonathan SymondsIndividual3,500UK£15.71
01 Feb 24BuyUK£306,430Julie BrownIndividual19,360UK£15.83
20 Dec 23BuyUK£28,907Jonathan SymondsIndividual2,000UK£14.45
20 Dec 23BuyUK£6,929Urs RohnerIndividual478UK£14.50

Insider Trading Volume

Insider Buying: GSK insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of GSK?
Owner TypeNumber of SharesOwnership Percentage
Public Companies1,520,2540.0373%
Individual Insiders3,469,3610.085%
State or Government6,717,4270.165%
Private Companies45,842,1421.12%
Employee Share Scheme72,477,7821.78%
General Public467,015,67611.4%
Institutions3,483,457,05985.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 50.67% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.13%
Dodge & Cox
372,510,492UK£5.0b-0.9%2.09%
8.48%
BlackRock, Inc.
346,116,839UK£4.7b1.71%0.1%
4.7%
The Vanguard Group, Inc.
191,755,207UK£2.6b0.53%0.05%
2.24%
State Street Global Advisors, Inc.
91,492,561UK£1.2b1.22%0.06%
2.09%
Wellington Management Group LLP
85,113,207UK£1.2b20.1%0.22%
2.05%
FMR LLC
83,733,483UK£1.1b-3.52%0.08%
1.98%
Legal & General Investment Management Limited
80,832,617UK£1.1b-3.73%0.26%
1.98%
Schroder Investment Management Limited
80,779,184UK£1.1b17.1%0.9%
1.9%
Norges Bank Investment Management
77,390,644UK£1.0b-10.1%0.11%
1.78%
GlaxoSmithKline Employee Trust
72,477,782UK£981.0m-1.2%no data
1.63%
UBS Asset Management AG
66,697,894UK£902.8m8.32%0.12%
1.24%
Mondrian Investment Partners Limited
50,764,058UK£687.1m12%5.84%
1.2%
Silchester International Investors LLP
49,126,050UK£664.9m-2.54%3.27%
1.12%
GlaxoSmithKline plc, Shareview Client
45,842,142UK£620.5m-1.97%no data
1.07%
HSBC Global Asset Management (UK) Limited
43,586,855UK£589.9m-3.5%0.31%
1.01%
Royal Bank of Canada Trust Company (Bahamas) Limited, Asset Management Arm
41,053,198UK£555.7m-1.91%19.14%
0.95%
Fisher Asset Management, LLC
38,829,470UK£525.6m0.18%0.28%
0.88%
Aviva Investors Global Services Ltd.
35,767,094UK£484.1m-11.8%0.8%
0.82%
Columbia Management Investment Advisers, LLC
33,581,146UK£454.5m-15.5%0.13%
0.78%
Royal London Asset Management Ltd.
31,962,532UK£432.6m8.73%0.71%
0.74%
Strategic Advisers LLC
30,262,910UK£409.6m-0.18%0.21%
0.73%
PRIMECAP Management Company
29,707,510UK£402.1m2.36%0.37%
0.73%
Causeway Capital Management LLC
29,646,365UK£401.3m8.55%2.23%
0.72%
Franklin Resources, Inc.
29,376,809UK£397.6m-2.6%0.18%
0.72%
BNY Asset Management
29,268,752UK£396.2m26.6%0.09%